Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

β-Blockers associated with no class-specific survival benefit in acute intracerebral hemorrhage.

Shoup JP, Winkler J, Czap A, Staff I, Fortunato G, McCullough LD, Sansing LH.

J Neurol Sci. 2014 Jan 15;336(1-2):127-31. doi: 10.1016/j.jns.2013.10.022. Epub 2013 Oct 22.

2.

Is β-blocker (atenolol) a preferred antihypertensive in acute intracerebral hemorrhage?

Kalita J, Misra UK, Kumar B.

Neurol Sci. 2013 Jul;34(7):1099-104. doi: 10.1007/s10072-012-1210-y. Epub 2012 Oct 9.

PMID:
23053838
3.

Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH) II: design, methods, and rationale.

Qureshi AI, Palesch YY.

Neurocrit Care. 2011 Dec;15(3):559-76. doi: 10.1007/s12028-011-9538-3.

4.

Effect of β-Adrenergic Antagonists on In-Hospital Mortality after Ischemic Stroke.

Phelan C, Alaigh V, Fortunato G, Staff I, Sansing L.

J Stroke Cerebrovasc Dis. 2015 Sep;24(9):1998-2004. doi: 10.1016/j.jstrokecerebrovasdis.2015.04.035. Epub 2015 Jul 9.

5.

Effect of statin use during hospitalization for intracerebral hemorrhage on mortality and discharge disposition.

Flint AC, Conell C, Rao VA, Klingman JG, Sidney S, Johnston SC, Hemphill JC, Kamel H, Davis SM, Donnan GA.

JAMA Neurol. 2014 Nov;71(11):1364-71. doi: 10.1001/jamaneurol.2014.2124.

PMID:
25244578
6.

Impact of preadmission treatment with calcium channel blockers or beta blockers on short-term mortality after stroke: a nationwide cohort study.

Sundbøll J, Schmidt M, Horváth-Puhó E, Christiansen CF, Pedersen L, Bøtker HE, Sørensen HT.

BMC Neurol. 2015 Mar 7;15:24. doi: 10.1186/s12883-015-0279-3.

7.

Association between cardiovascular outcomes and antihypertensive drug treatment in older women.

Wassertheil-Smoller S, Psaty B, Greenland P, Oberman A, Kotchen T, Mouton C, Black H, Aragaki A, Trevisan M.

JAMA. 2004 Dec 15;292(23):2849-59. Erratum in: JAMA. 2005 Apr 6;293(13):1594.

PMID:
15598916
8.

Long-term improvement in outcome after intracerebral hemorrhage in patients treated with statins.

Winkler J, Shoup JP, Czap A, Staff I, Fortunato G, McCullough LD, Sansing LH.

J Stroke Cerebrovasc Dis. 2013 Nov;22(8):e541-5. doi: 10.1016/j.jstrokecerebrovasdis.2013.06.015. Epub 2013 Jul 16.

PMID:
23867041
9.

Confounding by indication in retrospective studies of intracerebral hemorrhage: antiepileptic treatment and mortality.

Battey TW, Falcone GJ, Ayres AM, Schwab K, Viswanathan A, McNamara KA, DiPucchio ZY, Greenberg SM, Sheth KN, Goldstein JN, Rosand J.

Neurocrit Care. 2012 Dec;17(3):361-6. doi: 10.1007/s12028-012-9776-z.

10.

Anti-adrenergic medications and edema development after intracerebral hemorrhage.

Sansing LH, Messe SR, Cucchiara BL, Lyden PD, Kasner SE.

Neurocrit Care. 2011 Jun;14(3):395-400. doi: 10.1007/s12028-010-9498-z.

PMID:
21264527
11.

Oral beta-blockers for mild to moderate hypertension during pregnancy.

Magee LA, Duley L.

Cochrane Database Syst Rev. 2000;(4):CD002863. Review. Update in: Cochrane Database Syst Rev. 2003;(3):CD002863.

PMID:
11034777
12.

β-Blocker withdrawal is preferable for accurate interpretation of the aldosterone-renin ratio in chronically treated hypertension.

Browne GA, Griffin TP, O'Shea PM, Dennedy MC.

Clin Endocrinol (Oxf). 2016 Mar;84(3):325-31. doi: 10.1111/cen.12882. Epub 2015 Sep 22.

PMID:
26300226
13.

Prior statin use reduces mortality in intracerebral hemorrhage.

Naval NS, Abdelhak TA, Zeballos P, Urrunaga N, Mirski MA, Carhuapoma JR.

Neurocrit Care. 2008;8(1):6-12.

PMID:
17701108
14.

Beta2-adrenergic receptor genotype and survival among patients receiving beta-blocker therapy after an acute coronary syndrome.

Lanfear DE, Jones PG, Marsh S, Cresci S, McLeod HL, Spertus JA.

JAMA. 2005 Sep 28;294(12):1526-33.

PMID:
16189366
15.

Early care limitations independently predict mortality after intracerebral hemorrhage.

Zahuranec DB, Brown DL, Lisabeth LD, Gonzales NR, Longwell PJ, Smith MA, Garcia NM, Morgenstern LB.

Neurology. 2007 May 15;68(20):1651-7.

PMID:
17502545
16.

Poor utility of grading scales in acute intracerebral hemorrhage: results from the INTERACT2 trial.

Heeley E, Anderson CS, Woodward M, Arima H, Robinson T, Stapf C, Parsons M, Lavados PM, Huang Y, Wang Y, Crozier S, Parry-Jones A, Wang J, Chalmers J; INTERACT2 Investigators..

Int J Stroke. 2015 Oct;10(7):1101-7. doi: 10.1111/ijs.12518. Epub 2015 Jun 4.

PMID:
26044442
17.

The Effect of β-blockade on Survival After Isolated Severe Traumatic Brain Injury.

Mohseni S, Talving P, Thelin EP, Wallin G, Ljungqvist O, Riddez L.

World J Surg. 2015 Aug;39(8):2076-83. doi: 10.1007/s00268-015-3039-z.

PMID:
25809062
18.

Oral beta-blockers for mild to moderate hypertension during pregnancy.

Magee LA, Duley L.

Cochrane Database Syst Rev. 2003;(3):CD002863. Review.

PMID:
12917933
19.

Association of subdural hematoma with increased mortality in lobar intracerebral hemorrhage.

Patel PV, FitzMaurice E, Nandigam RN, Auluck P, Viswanathan A, Goldstein JN, Rosand J, Greenberg SM, Smith EE.

Arch Neurol. 2009 Jan;66(1):79-84. doi: 10.1001/archneur.66.1.79.

20.

Post-thrombolysis intracerebral hemorrhage: data from the Spanish Register ARIAM.

Ruiz-Bailén M, Brea-Salvago JF, de Hoyos EA, Rucabado-Aguilar L, Escudero GG, Martínez-Escobar S, Rossel-Ortiz F, Mellado-Vergel JF, Ruiz-Ferrón F, Morante-Valle A, Gómez-Jiménez FJ, Colmenero-Ruiz M; ARIAM Group..

Crit Care Med. 2005 Aug;33(8):1829-38.

PMID:
16096462

Supplemental Content

Support Center